Scandinavian ChemoTech
3.67 SEK
-1.08 %
Less than 1K followers
CMOTEC B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-1.08 %
+19.93 %
-11.78 %
-26.89 %
-19.69 %
+176.98 %
-27.66 %
-79.08 %
-90.26 %
Scandinavian ChemoTech is a Swedish company that develops and markets medical technology based on electrochemotherapy for the treatment of cancer. The company offers systems and solutions to clinics in oncology and veterinary medicine and has operations in international markets, including India and Southeast Asia. The company was founded in 2015 and is headquartered in Lund, Sweden.
Read moreMarket cap
93.42M SEK
Turnover
45.82K SEK
Revenue
12.29M
EBIT %
-52.61 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
28.4
2026
Interim report Q1'26
5.5
2026
General meeting '26
11.8
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
(RETRANS) Scandinavian ChemoTech Starts 2026 Strong with Best First Quarter in Company History
Scandinavian ChemoTech Starts 2026 Strong with Best First Quarter in Company History
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools